Home Cart 0 Sign in  

[ CAS No. 129940-50-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 129940-50-7
Chemical Structure| 129940-50-7
Structure of 129940-50-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 129940-50-7 ]

Related Doc. of [ 129940-50-7 ]

Alternatived Products of [ 129940-50-7 ]

Product Details of [ 129940-50-7 ]

CAS No. :129940-50-7 MDL No. :MFCD00273373
Formula : C22H20O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XFSXUCMYFWZRAF-NRFANRHFSA-N
M.W : 316.39 Pubchem ID :7168113
Synonyms :

Calculated chemistry of [ 129940-50-7 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.18
Num. rotatable bonds : 6
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 94.74
TPSA : 21.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.41
Log Po/w (XLOGP3) : 4.44
Log Po/w (WLOGP) : 4.29
Log Po/w (MLOGP) : 3.68
Log Po/w (SILICOS-IT) : 5.37
Consensus Log Po/w : 4.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.76
Solubility : 0.00553 mg/ml ; 0.0000175 mol/l
Class : Moderately soluble
Log S (Ali) : -4.62
Solubility : 0.00767 mg/ml ; 0.0000242 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.67
Solubility : 0.00000683 mg/ml ; 0.0000000216 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.39

Safety of [ 129940-50-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 129940-50-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 129940-50-7 ]
  • Downstream synthetic route of [ 129940-50-7 ]

[ 129940-50-7 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 76-83-5 ]
  • [ 57044-25-4 ]
  • [ 129940-50-7 ]
YieldReaction ConditionsOperation in experiment
73% With dmap; triethylamine In dichloromethane at 20℃; Inert atmosphere; Cooling Trityl protected glycidol derivative 401 was prepared as described previously (Schweizer, et al., Synthesis 2007, 3807-3814; which is incorporated herein by reference.) A solution of (/?)-glycidol (5.0 g, 61 mmol) in CH2Cl2 (30 mL) was added by syringe to a stirred solution of trityl chloride (18.6 g, 66.8 mmol) and triethylamine (16.9 mL, 122 mmol) in CH2Cl2 (67 mL) in an ice bath under argon. DMAP (742 mg, 6.08 mmol) was added to the reaction mixture following addition of the glycidol. The reaction was allowed to warm to room temperature. After 14 hours, the reaction mixture was diluted with 300 mL saturated aqueous NH4CI. The mixture was further diluted to ~ 1 L with water to dissolve precipitated salts. The product was extracted from the quenching solution with Et2O (3 x); combined ethereal layers were washed with brine, dried over MgSO4, filtered through paper, and concentrated by rotary evaporation to a white solid. The crude product was purified by recrystallization from boiling MeOH (200 mL) affording the desired product 401 (14.1 g, 73percent) as white crystals. NMR analysis of this material was consistent with that reported in the literature. (Schweizer, et al., Synthesis 2007, 3807-3814.)
Reference: [1] Synthesis, 2007, # 24, p. 3807 - 3814
[2] Tetrahedron Letters, 2000, vol. 41, # 33, p. 6323 - 6326
[3] Journal of Organic Chemistry, 2003, vol. 68, # 8, p. 3026 - 3042
[4] Journal of Organic Chemistry, 2013, vol. 78, # 11, p. 5172 - 5183
[5] Patent: WO2010/53572, 2010, A2, . Location in patent: Page/Page column 163
[6] ACS Chemical Neuroscience, 2018,
[7] Tetrahedron Letters, 1994, vol. 35, # 20, p. 3243 - 3246
[8] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 16, p. 2229 - 2236
[9] Journal of Organic Chemistry, 1998, vol. 63, # 6, p. 1961 - 1973
[10] Tetrahedron Letters, 1999, vol. 40, # 12, p. 2371 - 2374
[11] Patent: WO2006/14429, 2006, A2, . Location in patent: Page/Page column 11; figure 3
  • 2
  • [ 76-83-5 ]
  • [ 60456-23-7 ]
  • [ 129940-50-7 ]
Reference: [1] Patent: US6448422, 2002, B1,
  • 3
  • [ 65291-30-7 ]
  • [ 16975-62-5 ]
  • [ 129940-50-7 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 19, p. 8058 - 8061
  • 4
  • [ 65291-30-7 ]
  • [ 124-38-9 ]
  • [ 17327-06-9 ]
  • [ 22147-30-4 ]
  • [ 65291-30-7 ]
  • [ 129940-50-7 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2007, vol. 80, # 7, p. 1391 - 1401
  • 5
  • [ 203250-06-0 ]
  • [ 129940-50-7 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 6, p. 1961 - 1973
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 129940-50-7 ]

Ruboxistaurin Related Intermediates

Chemical Structure| 57044-25-4

[ 57044-25-4 ]

(R)-Oxiran-2-ylmethanol

Related Functional Groups of
[ 129940-50-7 ]

Aryls

Chemical Structure| 2979-22-8

[ 2979-22-8 ]

2-Methoxy-2-phenylethanol

Similarity: 0.83

Chemical Structure| 95061-47-5

[ 95061-47-5 ]

(R)-2-Hydroxy-1,2,2-triphenylethyl acetate

Similarity: 0.79

Chemical Structure| 699-73-0

[ 699-73-0 ]

3-Phenyloxetan-3-ol

Similarity: 0.79

Chemical Structure| 14618-80-5

[ 14618-80-5 ]

(R)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 16495-13-9

[ 16495-13-9 ]

(S)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Ethers

Chemical Structure| 2979-22-8

[ 2979-22-8 ]

2-Methoxy-2-phenylethanol

Similarity: 0.83

Chemical Structure| 14618-80-5

[ 14618-80-5 ]

(R)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 16495-13-9

[ 16495-13-9 ]

(S)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 4799-67-1

[ 4799-67-1 ]

3-(Benzyloxy)propane-1,2-diol

Similarity: 0.77

Chemical Structure| 70448-03-2

[ 70448-03-2 ]

2-(Benzyloxy)propan-1-ol

Similarity: 0.77

Related Parent Nucleus of
[ 129940-50-7 ]

Epoxides

Chemical Structure| 2930-05-4

[ 2930-05-4 ]

2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 14618-80-5

[ 14618-80-5 ]

(R)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 16495-13-9

[ 16495-13-9 ]

(S)-2-((Benzyloxy)methyl)oxirane

Similarity: 0.77

Chemical Structure| 121-39-1

[ 121-39-1 ]

Ethyl 3-phenylglycidate

Similarity: 0.64

Chemical Structure| 51481-10-8

[ 51481-10-8 ]

(2R,2'S,3R,5R,5aR,6S,9aR)-3,6-Dihydroxy-5a-(hydroxymethyl)-5,8-dimethyl-2,3,4,5,5a,6-hexahydrospiro[2,5-methanobenzo[b]oxepine-10,2'-oxiran]-7(9aH)-one

Similarity: 0.59